Dimensional Fund Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
145,256
+15,109
| +12% | +$175K | ﹤0.01% | 2803 |
|
|
2025
Q1 | $1.14M | Buy |
130,147
+16,765
| +15% | +$147K | ﹤0.01% | 2854 |
|
|
2024
Q4 | $1.63M | Sell |
113,382
-23,956
| -17% | -$344K | ﹤0.01% | 2833 |
|
|
2024
Q3 | $3.1M | Sell |
137,338
-77,754
| -36% | -$1.76M | ﹤0.01% | 2670 |
|
|
2024
Q2 | $4.19M | Sell |
215,092
-261,145
| -55% | -$5.08M | ﹤0.01% | 2551 |
|
|
2024
Q1 | $17.9M | Sell |
476,237
-25,177
| -5% | -$945K | ﹤0.01% | 2048 |
|
|
2023
Q4 | $28.1M | Sell |
501,414
-2,211
| -0.4% | -$124K | 0.01% | 1813 |
|
|
2023
Q3 | $20.8M | Buy |
503,625
+297,818
| +145% | +$12.3M | 0.01% | 1899 |
|
|
2023
Q2 | $11.5M | Buy |
205,807
+176,752
| +608% | +$9.87M | ﹤0.01% | 2194 |
|
|
2023
Q1 | $1.62M | Buy |
29,055
+18,488
| +175% | +$1.03M | ﹤0.01% | 2788 |
|
|
2022
Q4 | $385 | Sell |
10,567
-2,639
| -20% | -$96 | ﹤0.01% | 3089 |
|
|
2022
Q3 | $377K | Sell |
13,206
-20,130
| -60% | -$575K | ﹤0.01% | 3104 |
|
|
2022
Q2 | $1.51M | Sell |
33,336
-44,392
| -57% | -$2.01M | ﹤0.01% | 2823 |
|
|
2022
Q1 | $5.91M | Buy |
77,728
+11,731
| +18% | +$892K | ﹤0.01% | 2488 |
|
|
2021
Q4 | $9.83M | Buy |
65,997
+1,732
| +3% | +$258K | ﹤0.01% | 2316 |
|
|
2021
Q3 | $9.36M | Buy |
64,265
+3,378
| +6% | +$492K | ﹤0.01% | 2359 |
|
|
2021
Q2 | $11.9M | Buy |
60,887
+27,941
| +85% | +$5.47M | ﹤0.01% | 2280 |
|
|
2021
Q1 | $5.96M | Buy |
32,946
+19,324
| +142% | +$3.49M | ﹤0.01% | 2514 |
|
|
2020
Q4 | $1.93M | Buy |
13,622
+7,671
| +129% | +$1.09M | ﹤0.01% | 2819 |
|
|
2020
Q3 | $742K | Buy |
+5,951
| New | +$742K | ﹤0.01% | 2994 |
|